Thrombolysis, anticoagulation, and reocclusion

This publication has 20 references indexed in Scilit:

• Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarction
  The American Journal of Cardiology, 1991
• Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
  Circulation, 1990
• In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin
  The Lancet, 1990
• Pharmacology of anistreplase
  Clinical Cardiology, 1990
• A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.
  Circulation, 1989
• Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
  Journal of the American College of Cardiology, 1988
• Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator.
  Circulation, 1988
• Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: Prediction of clinical outcome
  American Heart Journal, 1988
• Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator Complex
  Drugs, 1987
• Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction.
  Circulation, 1986